Prostate cancer screening is controversial due to overdiagnosis and overtreatment of non-fatal disease, and the United States Preventive Services Task Force strongly recommends against prostate-specific antigen (PSA) screening for prostate cancer [6]. Here, KLK3 is linked to Familial prostate cancer.